Access to Surgery and Outcomes for Papillary Thyroid Cancer Following the 2015 American Thyroid Association Guideline Changes

Abstract

Background

The extent of surgical treatment for intermediate-sized (1.0-4.0 cm) papillary thyroid cancer (PTC) has been widely debated. This study evaluates the impact of the 2015 ATA guidelines on the surgical treatment trends of intermediate-sized PTC tumors.

Methods

Using the Surveillance, Epidemiology, and End Results (SEER) database, patients with intermediate-sized PTC tumors were separated into pre-ATA guideline changes (2000-2015) or post-ATA changes (2016-2020) groupings. Lobectomy or total thyroidectomy usage was compared with logistic regression analyses.

Results

The rate of lobectomy increased from a mean usage rate of 10.0% pre-ATA updates to 18.6% post-guideline changes (P < 0.001). Logistic regression showed the rate of thyroidectomy decreased post-ATA changes (P < 0.001, odds ratio (OR) = 0.607). Additionally, total thyroidectomy was associated with improved survival (P < 0001, HR = 0.624) and); tumors sized 2.1 cm-3.0 cm (P < 0001, HR = 1.824) and 3.1 cm-4.0 cm (P < 0001, HR = 2.927) were associated with worse survival.

Conclusions

After the 2015 ATA guideline changes there has been a significant increase in the rate of lobectomy for intermediate-sized PTC tumors occurred after the 2015 ATA guideline changes, reflecting the guidelines supporting less aggressive surgical management in low-risk cases.

Keywords

papillary thyroid cancer lobectomy thyroidectomy surgical trends guideline changes ATA

Get full access to this article

View all access options for this article.

References

Aschebrook-Kilfoy

Ward

Sabra

Devesa

. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid Off J Am Thyroid Assoc. 2011;21(2):125-134. doi:10.1089/thy.2010.0021.

Barney

Hitchcock

Sharma

Shrieve

Tward

. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33(5):645-649. doi:10.1002/hed.21504.

Haugen

Alexander

Bible

, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. doi:10.1089/thy.2015.0020.

Ringel

Sosa

Baloch

, et al. 2025 American thyroid association management guidelines for adult patients with differentiated thyroid cancer. Thyroid®. 2015;352025(8):31. Accessed November 14, https://doi.org/10.1177/10507256251363120.

Kandil

Krishnan

Noureldine

Yao

Tufano

. Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Oto-Rhino-Laryngol Its Relat Spec. 2013;75(1):6-17. doi:10.1159/000345498.

Lang

BHH

Wong

CKH

Wong

Chu

KKW

Shek

TWH

. Effect of thyroid remnant volume on the risk of hypothyroidism after hemithyroidectomy: a prospective study. Ann Surg Oncol. 2017;24(6):1525-1532. doi:10.1245/s10434-016-5743-9.

Clark

OH.

Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg. 1982;196(3):361-370. doi:10.1089/thy.2015.0020.

Montgomery

Fazendin

Chen

Broman

. Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension. Am J Surg. 2024;228:173-179. doi:10.1016/j.amjsurg.2023.09.021.

Hirshoren

Kaganov

Weinberger

, et al. Thyroidectomy practice after implementation of the 2015 American thyroid association guidelines on surgical options for patients with well-differentiated thyroid carcinoma. JAMA Otolaryngol Head Neck Surg. 2018;144(5):427-432. doi:10.1001/jamaoto.2018.0042.

10.

Ullmann

Gray

Stefanova

, et al. The 2015 American thyroid association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer. Surgery. 2019;166(3):349-355. doi:10.1016/j.surg.2019.03.002.

11.

Gordon

Dublin

Patel

, et al. American thyroid association guidelines and national trends in management of papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg. 2022;148(12):1156-1163. doi:10.1001/jamaoto.2022.3360.

12.

Patel

Klopper

Cottrill

. Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities. Front Endocrinol. 2023;14:1101410. doi:10.3389/fendo.2023.1101410.

13.

Kim

Lee

Kim

, et al. Management of 2–4 cm papillary thyroid carcinoma: risk of recurrence compared to 1–2 cm and >4 cm. J Endocr Surg. 2020;20(4):78-87. doi:10.16956/jes.2020.20.4.78.

14.

Rajjoub

Yan

Calcatera

, et al. Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers. Surgery. 2018;163(5):1134-1143. doi:10.1016/j.surg.2017.12.026.

15.

Choi

Lee

Kim

, et al. Prevalence of postoperatively detected high-risk features in 2- to 4-cm papillary thyroid cancers. J Clin Endocrinol Metab. 2022;107(10):e4124-e4131. doi:10.1210/clinem/dgac457.

16.

Worrall

Papachristos

Aniss

, et al. Lobectomy and completion thyroidectomy rates increase after the 2015 American thyroid association differentiated thyroid cancer guidelines update. Endocr Oncol Bristol Engl. 2023;3(1):e220095. doi:10.1530/EO-22-0095.

17.

Zhang

Chen

. Total thyroidectomy versus lobectomy for papillary thyroid cancer. Medicine (Baltim). 2020;99(6):e19073. doi:10.1097/MD.0000000000019073.

18.

Alhanafy

Elsisy

AAE

Alanazi

Abuelfetouh

Alabassy

. Survival rate between total thyroidectomy and lobectomy in papillary thyroid cancer. Egypt J Surg. 2024;43(1):96-100. doi:10.4103/ejs.ejs_247_23.

19.

Konda

Lewis

Furness

Miller

Metcalfe

Ellard

. Surgeon views regarding the adoption of a novel surgical innovation into clinical practice: systematic review. BJS Open. 2024;8(1):zrad141. doi:10.1093/bjsopen/zrad141.